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Early blood grouping techniques relied heavily on 
hemagglutination for the identification of new blood 
group antigens. To the dismay of many serologists, 
membrane biologists and biochemists began using 
these serologically defined antigens as markers on 
membrane proteins to assist them in their biochemical 
analyses. Thus, serologists had to become proficient 
with terms such as sodium-dodecyl sulfate polyacryl- 
amide gel electrophoresis, sialyl-glycoproteins, and 
galactosyl-transferase. Today, molecular biologists are 
breaking down blood group genes, amplifying viral 
DNA, and, in general, presenting a challenge to serol- 
ogists. The purpose of this review is to define some of 
the more applicable molecular terminology and to 
show how modern molecular genetic techniques can, 
and will, be utilized in transfusion medicine. 
Restriction Fragment Length Polymorphism 
(RFLP) Analysis 
One of the most utilized methods in molecular 
genetics is the Southern blotting technique first 
described by Dr. E.M. Southern.1 It has been a pow- 
erful tool for analyzing the eukaryotic genome, in pre- 
liminary analyses prior to gene cloning, and for the 
determination of blood group genes, including HLA. 
It is therefore important to have a basic understand- 
ing of the molecular genetic terminology as well as the 
molecular genetic technique. 
The first step in Southern blotting is to obtain DNA 
for analysis. (Note: When RNA is substituted for DNA, 
the procedure is called Northern blotting.) Sources of 
DNA can be tissues in which the gene under study is 
expressed, e.g., bone marrow, peripheral leukocytes, 
or cell cultures. Genomic DNA is usually prepared by 
either a salting-out technique2 or another procedure 
that uses proteinase K digestion followed by phenol- 
chloroform extraction and ethanol precipitation. 
The former technique is less time consuming and 
does not utilize toxic chemicals. However, it has 
been my experience that this technique yields DNA 
that may not be easily digested by restriction enzymes, 
which react better in a no-salt or low-salt environment. 
Once the DNA is in hand, it can be digested by 
restriction enzymes. Restriction endonucleases are 
enzymes that occur naturally in various strains of bac- 
teria. Each enzyme is named after its host organism; 
for example, Escherichia coli produces an enzyme 
called Eco RI. Each enzyme cuts DNA of a specific 
length of base pairs (usually 4-6) at a specific site. The 
cut may be either blunt or staggered (see Figure 1). A 
blunt cut divides the two pieces evenly into halves, 
while a staggered cut leaves overhanging edges. The 
latter cut is useful in cloning techniques. 
Blunt Cut 
5’ G T T v A A C  Hpa I recognizes 
3’ C A A ^ T T G  6 base pairs 
Staggered Cut 
5’ G v A A T T C  Eco RI recognizes 
3’ C T T ^ A T G  6 base pairs 
Pig. 1. Examples of how restriction endonucleases can cleave DNA 
The fragments that result from the digestion are 
now separated by agarose gel electrophoresis. The 
DNA fragments contained in the gel and appropriate 
size markers can be stained with ethidium bromide 
and visualized by ultraviolet light. A picture may be 
taken at this time to serve as a permanent record. 
Since the agarose gel is too bulky to be handled easi- 
ly, the separated DNA pieces are transferred to a solid 
support matrix such as nitrocellulose, or a nylon 
membrane. Once the replica of DNA, i.e., the 
Southern blot, is made, it can be probed. 
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A probe is a piece of DNA having a sequence com- 
plementary to the one under study Probes can be one 
of several types, including complementary DNA 
(cDNA), genomic DNA, or oligonucleotides. 
Oligonucleotide probes are artificially manufactured 
pieces of DNA whose sequences are generated based 
on known amino acid sequences. The probe can be 
labeled with a radioisotope, such as 32P: or with a non- 
radioactive enzyme such as alkaline phosphatase. 
Matching sequences are then visualized by a proce- 
dure known as autoradiography. In this method a 
piece of X-ray film is exposed to the blot, which has 
been hybridized with the labeled probe. In the case of 
32P-labeled probes, the radioactive decay causes 
exposure of the film. The enzyme-labeled probes will 
emit light when incubated with a chemiluminescent 
substrate, thus exposing the film. 
When the blots are fully developed, one will see a 
series of bands based on fragment size. If DNA from 
several individuals is analyzed, one may see different 
banding patterns, even when a single enzyme is used 
for the digest. These RFLPs are due to a change in 
the base pair sequence of DNA that is recognized by 
the restriction enzyme and that results in a change in 
the size of the DNA fragments. The mutations can be 
in either the coding (exon) or noncoding (intron) 
areas of the gene. 
One very useful application of RFLP analyses has 
been determination of HLA genes in transplant 
patients, although even this technology is becoming 
obsolete as polymerase chain reaction (PCR) and 
allele-specific oligonucleotide probes become more 
commonplace. Another example of the usefulness of 
RFLPs is the detection of an O gene in the heterozy- 
gous state, i.e., AO or BO. Since an O gene does not 
express a detectable blood group antigen, it is impos- 
sible to detect its presence in the heterozygous state 
using serologic techniques. Persons with an O gene 
have a base pair deletion that results in the loss of a 
BstE II site and the creation of a new Kpn I site.3 Thus, 
by subjecting DNA from these individuals to Southern 
blot analysis, the presence of the O gene can be ascer- 
tained (see Figure 2). This technique may be particu- 
larly useful in cases of disputed paternity. 
PCR and Allele-Specific Probes 
Since the first report of DNA amplification using the 
PCR, the number of different applications has grown 
A or B Gene 
5’ G v G T G A C C C  
3’ C C A C T G G ^ G  





3’ C ^ C A - T G G G  
I restriction site 
Fig. 2.  Using the enzyme Kpn I, a base pair deletion in the O gene 
results in a restriction fragment length polymorphism as well 
loss of function for the resulting protein. 
steadily.4 The popularity of this technique is most l ie-  
ly due to its relative simplicity and high success rate. 
The PCR has been used to diagnose genetic disease, 
in forensic testing, in cases of paternity, to determine 
HLA genotypes in transplantation, and for viral testing 
of blood donors. However, only the applications most 
pertinent to the field of immunogenetic and transfu- 
sion medicine will be discussed here. 
The PCR is an in vitro method for the enzymatic 
synthesis of specific DNA sequences. It uses two 
oligonucleotide primers that hybridize to opposite 
DNA strands and that flank the region of interest. 
Thus, as with the previous molecular techniques, one 
needs a source of DNA to amplify. One advantage of 
this technique is that only a small amount of DNA is 
necessary, since the reactions are typically done in 
small total volumes (50-100 µL). 
The DNA is mixed with a reaction buffer, 
nucleotides (dATP, dCTP, dGTP, dTTP), the appropri- 
ate oligonucleotide primer, and Taq polymerase-an 
enzyme that synthesizes a new strand of DNA. 
Selection of efficient and specific primers is critical for 
64 I M M U N O H E M A T O L O G Y ,  V O L U M E  9 ,  N U M B E R  3 ,  1 9 9 3  
Molecular genetic techniques 
a successful reaction. Primers should have a random 
base distribution avoiding long stretches of purines or 
pyrimidines. It is also important that sequences with 
significant secondary structure be avoided. Finally, the 
primers should not be complementary or have 3’ over- 
laps, as this will result in a condition known as 
“primer dimer.” 
Taq is a thermal stable DNA polymerase obtained 
from the bacteria that live in hot springs, i.e., 
Thermus aquaticus. In the PCR procedure, the tar- 
get DNA is first denatured by heating to 90-95°C. 
The primers are allowed to base pair or anneal to the 
DNA by a brief cooling to 40-60°C, followed by heat- 
ing to 70-75°C. The Taq polymerase then fills in the 
remainder of the new DNA strand, resulting in two 
molecules of DNA, where originally there had been 
one. Because these primer extension products can 
serve as templates in the next cycle, the number of 
target DNA copies double at each cycle. For example, 
after 20 PCR cycles there is a million-fold amplifica- 
tion of DNA. 
Following the amplification process, the DNA sam- 
ples can be blotted onto nitrocellulose. Since the typ- 
ical thermocycler has 96 wells, a “dot blot” of all 96 
samples can be made at one time. The blot is then 
hybridized to a labeled probe and interpreted, 
following autoradiography as previously described. 
PCR techniques are finding their way into clinical 
medicine and will eventually have an impact on trans- 
fusion medicine. One of the first applications of the 
PCR was the prenatal diagnosis of sickle cell anemia; 
however, its current application extends to many of 
the hereditary hemoglobinopathies. DNA can be 
extracted for these tests by heat-alkali denaturation of 
the fetal cells obtained through chorion villus sam- 
pling or amniocentesis. The technique is attractive 
because rapid results can be obtained. 
One of the most pertinent applications for the PCR 
is in the transplantation setting. Polymorphisms in the 
HLA genes have traditionally been identified using 
serologic (HLA-A, B, DR, DQ) or cellular (HLA-DP) 
techniques. Serologic techniques may have as much 
as a 40 percent error rate, especially in ethnic minori- 
ties.’ More recently, HLA class II typings have been 
performed using RFLP analysis. RFLP analysis is based 
on the detection of polymorphic restriction sites locat- 
ed in noncoding regions that are in linkage disequi- 
librium with allelic sequences. It is not therefore 
specific for a particular gene. Most of the HLA class II 
genes (HLA-D region) have been cloned and 
sequenced, making it easy to design specific primers 
and probes. Since the PCR method can amplify a spe- 
cific segment of genomic DNA, it has become an 
invaluable tool in typing HLA genes. 
The PCR method will revolutionize the detection of 
bacterial, fungal, and viral pathogens. The obvious 
interest for workers in the fields of blood banking and 
transfusion medicine is the detection of blood-borne 
viruses. However, before the PCR method can be used 
as a routine technique for donor testing, there will be 
large problems to overcome. Problems include the 
development of methods to rapidly obtain donor 
DNA and the elimination of contaminants. The latter 
problem may be difficult to solve, because a single 
copy of a viral genome, when amplified, can contam- 
inate an entire run. Precautions such as positive dis- 
placement pipettes and physical separation of 
reactions may help reduce carryover. 
The PCR method has already dramatically increased 
the sensitivity of hepatitis B virus detection. As few as 
three HBV genomes can be detected, i.e., ~300 
virus/mL of blood. Other human viruses detectable by 
this method include human immunodeficiency virus 
(HIV), human T-lymphotropic virus (HTLV), 
cytomegalovirus (CMV), and human papilloma virus 
(HPV).6-8 In fact, the PCR can be used to confirm the 
lack of virus particles in seronegative individuals who 
have been infected by HlV-1 or by other viruses.2,9,10 
Clearly this review can touch only on a few of the 
many applications of the PCR method. Other areas 
using the method include forensic testing and 
detection of oncogenes. 
Cloning and Sequencing 
Today, researchers are attacking the study of many 
blood groups at the gene level. The genes for ABO, 
Rh, MNSs, Gerbich, and Chido/Rodgers, to name only 
a few, have already been cloned. To understand the 
latest immunogenetics literature, one needs to be 
familiar with the basic terminology and techniques 
involved. 
Serologists know that a crossmatch can be done 
using techniques such as saline, albumin, LISS, PEG, 
antihuman-globulin, or any combination thereof Just 
as with crossmatching, many variations of gene 
cloning have evolved. It is impossible to discuss all of 
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them here, so what follows is a general approach to 
cloning a blood group gene (see Figure 3). 
Source total RNA 
v Oligo dT columns 
Selectively remove mRNA 
v reverse transcriptase 
Convert to cDNA 
v DNA polymerase 
Make double-stranded DNA 
v bacteriophage, etc 
Insert into cloning vector 
v E. coli 
Transfect into bacterial host 
v antibody or DNA probe 
Screen for positive clones 
v 
Propagate positives 
Pig. 3. A general scheme for the cloning of a blood group gene 
First, one can obtain a source of RNA for the 
cloning process. This source, in the case of blood 
group genes, is usually found in reticulocytes, or the 
fetal liver. The mRNA is selectively separated from the 
total RNA by passing it over an oligo-dT column. The 
thymines on the column will bind only to molecules 
of mRNA, since only this type of RNA has the comple- 
mentary poly-A tail. 
Next, the single-stranded mRNA must be converted 
to double-stranded DNA. This procedure involves syn- 
thesis of the first strand of cDNA using the enzyme 
reverse transcriptase. Using the first strand as a tem- 
plate, the second DNA strand can be generated using 
the Klenow fragment of DNA polymerase I. The hair- 
pin loop produced in this procedure is eventually 
cleaved with S l  nuclease. 
The double-stranded cDNA is then ready to be 
inserted into a cloning vector. A vector is an extra- 
chromosomal genetic element that can carry a recom- 
binant DNA molecule into a host bacterial cell. Vectors 
can be bacteriophages such as hgtll, plasmids such as 
pBR322, or cosmids. The cDNA must first be cleaved 
with a restriction enzyme, to prepare “overhangs” or 
“sticky ends” for insertion into the vector. The plasmid 
vector, which normally exists as a circular piece of 
DNA, must also be cleaved with the restriction enzyme 
in order to open it up. The cDNA is incubated with the 
vectors in the presence of T4 ligase, which joins the 
two ends of the DNA molecules together. If bacterio- 
phage h is being used as a vector, it must be further 
packaged into an infectious virus particle. 
Next, the vector is transfected or transferred into a 
bacterial host, where it is replicated with each repli- 
cation cycle of the bacterium. Bacteria containing 
recombinants are often identified by blue/white color 
selection on culture plates, while bacteria containing 
phage produce clear plaques. Each individual vector 
may contain a different cDNA, and only a few may 
contain the message from the gene being studied. 
This variety of vectors carrying many different cDNAs, 
propagated in a host bacteria, is called a cDNA library 
Recently, bacteriophage h has become the vector of 
choice, because these libraries are more easily ampli- 
fied and store indefinitely 
The blood group gene under study will be carried 
by those bacteria that have taken up the appropriate 
recombinant vector. These clones can be identified by 
screening a bacterial culture plate using a method 
very similar to Southern blotting. If the cDNA library 
is in an expression vector (hgtll), the blood group 
antigen will be expressed and the filter can be probed 
using a conjugated antibody to the antigen, such as 
anti-K1. Otherwise, the library can be screened with a 
synthetically prepared oligonucleotide probe based 
on part of a known amino acid sequence. Positive 
clones are then picked out and propagated until a 
pure culture is obtained. 
The cloned DNA is now ready to be purified and 
sequenced. Two basic methods are available for 
sequencing, i.e., the Maxam-Gilbert technique and the 
Sanger dideoxy technique.11,12 In the chemical degra- 
dation technique of Maxam and Gilbert,11 a DNA frag- 
ment is first radiolabeled, usually with 32P. The DNA is 
then partially degraded in a set of base-specific chem- 
ical reactions, which result in removal of the deriva- 
tive base and in subsequent cleavage of the DNA. The 
set of labeled fragments are run side by side on a poly- 
acrylamide gel electrophoresis, followed by autora- 
diography The pattern of bands on the X-ray film is 
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read sequentially to determine the DNA sequence. 
In the enzymatic method of Sanger,12 an oligonu- 
cleotide primer is hybridized to a single-strand DNA 
template. The strand is filled in, using 32P-labeled 
dATP, DNA polymerase, dideoxynucleotides, and nor- 
mal deoxynucleotides. The chain is terminated when 
a dideoxy-NTP is incorporated. A series of labeled frag- 
ments will result, which can then be separated by elec- 
trophoresis as described above. From the gene 
sequence, it is a simple matter to deduce the amino 
acid sequence of its protein. In fact, today it is often 
easier to sequence the gene than it is to determine the 
amino acid structure. 
The cloning of many of the blood group genes has 
shed light on old controversies in blood group genet- 
ics. For instance, Colin et have shown that there 
are two genes coding for the Rh polypeptide. One 
encodes for D,.while the other encodes for Cc/Ee. 
Through studies using DNA sequencing, it is now 
known that the O gene does produce a glycosyltrans- 
ferase; however, this enzyme is nonfunctional because 
of either a small deletion or base pair substitution.3,14 
Finally, alternative splicing of mRNA from a single gly- 
cophorin C gene results in two proteins being pro- 
duced, i.e., glycophorin C and D, which carry the 
Gerbich antigen.15 
Summary 
Today, it is necessary to have a basic understanding 
of molecular biology techniques in order to read and 
interpret the literature on blood groups and transfu- 
sion medicine. It will become imperative for bench 
technologists to have a working knowledge of these 
techniques, as they move out of the research setting 
and into the clinical laboratories. It is hoped that this 
review has provided a brief glimpse of the study of 
molecular genetics. 
Note: This review is an adaptation of the chapter 
“Basic Genetics,” which will appear in Modern Blood 
Banking and Transfusion Practices (3rd ed. DM 
Harmening, ed. New York: Garland Publishing, Inc., 
in press). 
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